Christopher J. DeRespino
Nessuna posizione attualmente
Storia della carriera di Christopher J. DeRespino
Precedenti posizioni note di Christopher J. DeRespino
Società | Posizione | Inizio | Fine |
---|---|---|---|
ADVERUM BIOTECHNOLOGIES, INC. | Comptroller/Controller/Auditor | 24/06/2021 | 27/08/2021 |
Direttore Finanziario/CFO | 24/06/2021 | 27/08/2021 | |
Corporate Officer/Principal | 18/02/2021 | 24/06/2021 | |
AMGEN INC. | Corporate Officer/Principal | 01/06/2018 | 01/02/2021 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Corporate Officer/Principal | - | - |
Formazione di Christopher J. DeRespino
The Leonard N Stern School of Business | Masters Business Admin |
The Johns Hopkins University | Undergraduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 6 |
Posizioni
Corporate Officer/Principal | 3 |
Comptroller/Controller/Auditor | 1 |
Director of Finance/CFO | 1 |
Settori
Health Technology | 4 |
Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 2 |
---|---|
ADVERUM BIOTECHNOLOGIES, INC. | Health Technology |
AMGEN INC. | Health Technology |
Aziende private | 1 |
---|---|
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Health Technology |